Загрузка...
p53 and MDM2 in Renal Cell Carcinoma: Biomarkers for Disease Progression and Future Therapeutic Targets?
Renal cell carcinoma (RCC) is the most common type of kidney cancer and follows an unpredictable disease course. To improve prognostication, a better understanding of critical genes associated with disease progression is required. The objective of this review was to focus attention on 2 such genes,...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3536467/ https://ncbi.nlm.nih.gov/pubmed/20052733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24841 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|